Novo Nordisk A/S (CPSE:NOVO B) announces an Equity Buyback for DKK 20,000 million worth of its shares.

Novo Nordisk A/S (CPSE:NOVO B) announces a share repurchase program. Under the program, the company will repurchase up to DKK 20,000 million worth of its shares. The share repurchase program will be valid for a period of 12 months.